Followers | 14 |
Posts | 1,650 |
Boards Moderated | 0 |
Alias Born | 11/01/2010 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
better a long than a flipper
I think longs should be on the bid. I think I saw shares sell as low as .092 yesterday.
$CTDT my guess would be as early as tomorrow and late as next week
$CTDT and we will hopefully have news and filings soon
$CTDT I'm no good with charts but I see we jumped from 80% buy to a 96% buy on BarChart http://stks.co/dVgW
I like to see anyone who owns a stock and want to see gains take mod positions
we have a new boardmark
I think you get 15 a day on a free account
$CTDT Whoa I'm missing the action! Busy day in the office
take a look at $CTDT news coming soon
$CTDT saw this on Google Finance not sure whether or not its worth a mention here
http://www.sbwire.com/press-releases/penny-stocks-under-review-tni-biotech-inc-graphite-corp-centaurus-diamond-technologies-inc-tapimmune-inc-257358.htm
Penny Stocks Under Review - TNI BIOTECH INC, Graphite Corp, Centaurus Diamond Technologies Inc, TapImmune Inc
Its new to me and probably also new to those new boardmarks
$CTDT 0.092 0.105 news coming soon
$CTDT .0910 .1050 news coming soon
Does the SEC allow companies to disclose that type of info in a blog post?
TriStar Wellness Solutions Signs Exclusive Global Licensing Option Agreement With Polytherapeutics for Treatment of Specific Skin Conditions and Wound Care
WESTPORT, Conn.--(BUSINESS WIRE)--
TriStar Wellness Solutions, Inc. (TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has signed an exclusive, three-year licensing option agreement with Polytherapeutics, Inc. for its PharmaDur® drug delivery technology, for over-the-counter (“OTC”) products focused on the treatment of specific skin conditions and wound care applications.
The licensing option agreement enables TriStar Wellness Solutions to continue development of novel products using the PharmaDur® technology. Upon successful product development and regulatory approval the licensing option will convert into a full global license for this important technology. This technology enables a more effective and convenient delivery of therapeutic active ingredients that is expected to support important and differentiated superiority claims relative to current market competitors.
PharmaDur® is the second development in TriStar Wellness Solutions’ wound care product line announced this month. Last week, TriStar announced its acquisition of HemCon Medical Technologies, a developer of bleeding and wound management technologies for surgical, healthcare, consumer and military markets, which will operate as a wholly owned subsidiary of TriStar.
“We are encouraged by the results of our initial testing of the PharmaDur® technology to deliver game-changing product performance that will greatly benefit consumers,” said John Linderman, President of TriStar Wellness Solutions. “We are pleased to have added this important technology to our growing portfolio of capabilities in the skin care and wound care space. Considered in conjunction with our recent acquisition of HemCon Medical Technologies, we believe we are quickly establishing ourselves as a formidable and growing player in this vital area of healthcare.”
Mr. Linderman continued, “We believe that long-term market success must be based on harnessing new science and technologies that deliver meaningful improvements in the quality of life for consumers. The PharmaDur® technology represents an exciting platform for TriStar that will span many unique product applications within the skin and wound care categories. TriStar is in an ideal position to find and apply technologies like PharmaDur® based on our strong internal product development and marketing expertise.”
“We are delighted to be collaborating with TriStar in this venture to produce high-value healthcare products for consumers,” said Kishore R. Shah, President of Polytherapeutics.
About PharmaDur® Technology
The PharmaDur® technology is based on novel polymer having a combination of both hydrophilic and hydrophobic characteristics, with long-lasting and controlled-release capabilities. Formulation of active ingredients with PharmaDur® polymer can significantly improve its performance when used topically. The performance improvement is attributed to PharmaDur® polymer’s unique combination of bioadhesion and controlled release capability. These properties enable formulation of pharmaceutical and personal care products, which exhibit long lasting effectiveness while minimizing or eliminating toxic and undesirable side effects.
About TriStar Wellness Solutions
TriStar Wellness Solutions, Inc. (TWSI) is a health and wellness company that targets under-met consumer opportunities in the OTC and professional marketplace. Its core strategy plans to meet the growing demand for personalized, care solutions by leveraging proprietary innovation and healthcare technology with the rapid transformation of the healthcare marketplace to create innovative, science based solutions and brands. TriStar recently acquired HemCon Medical Technologies Inc., a developer, manufacturer, and marketer of innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. It also owns the Beauté de MamanTM brand of women’s health products. Additional information is available at www.tstarwellness.com.
About Polytherapeutics
Polytherapeutics is a research and development company having a mission of developing unique value added and patent protected technologies and healthcare products. It is focussed on commercializing health and beauty products based on its unique bioadhesive PharmaDur® actives delivery technology.
Additional information is available at www.pharmadur.com.
Forward-Looking Statement
This press release for TriStar Wellness Solutions, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
Contact:
Dian Griesel Inc.
Cheryl Schneider/Susan Forman
212-825-3210
www.dgicomm.com
$CTDT scored some .095s I'm averaging down from the name change/promo from last year. Looks like we are moving in the right direction
$CWRN update to the intro looks good
Any of the mods can do it.
$CWRN yeah someone is desperate and thinks were stupid
Portland Business Journal reports on TriStar Wellness Solutions $TWSI acquisition of HemCon.
Monday's sale of HemCon Medical Technologies marked the end of an incredible run.
The Portland bandage maker rocketed from startup to $72.9 million in annual sales within a decade.
It seems laughable to suggest the company's $3 million sale — after a crippling legal battle and the loss of a giant contract to supply bandages to the Army — is good news.
But Dennis McNannay, executive director of the Oregon Bioscience Association, said there's a big upside.
Westport, Conn.-based TriStar Wellness Solutions Inc. (OTCBB: TWSI) which bought the company, will keep HemCon's Portland operations open.
That seemed doubtful when the company was crawling through the biggest Oregon bankruptcy of 2012.
HemCon is a key player in the state's bioscience industry, specifically the wound-care subset of the industry.
The bioscience industry employs more than 13,000, according to Oregon Bioscience Association research.
"Now that the (bankruptcy and legal fight) is behind them they have a new source of capital and an infusion of resources," McNannay said. "They have a chance to relaunch their innovative product line."
HemCon is most well known for a bandage that helps stop bleeding. The legal fight that precipitated the bankruptcy filing was over the technology used to make the bandage.
HemCon has since diversified into other technologies.
"No one fights this hard and this long over something that isn't valuable," McNannay said. "We wish it would have been over a lot quicker. Now HemCon can get back to creating very innovative products."
HemCon, founded in 2001, had revenues in 2012 of $6.5 million. Its world-class manufacturing facility had received funding from the U.S. Department of Defense to develop a hemorrhage-control bandage that became standard-issue for U.S. soldiers fighting in Iraq and Afghanistan. In addition to its Portland facility, HemCon also has facilities in Ireland and the Czech Republic.
.03 would be huge $CWRN
$XUII = Millions?
Kanye West's artist
yes he spelled the URL with a extra "i" though
edit: nevermind looks like it is fixed
Did I miss this jet?
Watch my LIVE Broadcast on @Xumanii (OTCQB: XUII)http://t.co/l916ZuHPq0 May 14th
— King Push (@PUSHA_T) May 13, 2013
Back on Breakout Boards $CWRN
I agree $CWRN
$TWSI Tristar Wellness Solutions Engages Dian Griesel Inc.
WESTPORT, Conn.--(BUSINESS WIRE)--TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a consumer health and wellness company that targets opportunities in the self-care and quality of life marketplace, has hired Dian Griesel Inc. (DGI) to serve as its investor relations and public relations agency. DGI’s investor and public relations teams will work towards the objective of increasing investor and public awareness of TriStar Wellness Solutions’ unique business model, unmet needs in consumer health and brands in the company’s portfolio.
“TriStar Wellness Solutions is focused on incubating science-based product innovations and addressing under-met consumer needs in niche, but highly engaged, consumer health and wellness spaces”
"TriStar Wellness Solutions is focused on incubating science-based product innovations and addressing under-met consumer needs in niche, but highly engaged, consumer health and wellness spaces," said John Linderman, President and CEO of TriStar Wellness Solutions. "Our core strategy aligns with the growing demand for simple, effective self-care solutions for a broad range of consumer conditions and disease states. We believe that we have a compelling investment thesis for investors and an exciting story to share with the media, and we look forward to leveraging DGI's experience, relationships and expertise."
DGI is a full-service corporate communications firm providing the equivalent of "large-cap" investor relations and public relations services to smaller emerging growth companies. Always budget-conscious, its carefully planned programs blend the best of traditional strategies with the opportunities of new media.
About TriStar Wellness Solutions
TriStar Wellness Solutions, Inc. (TWSI) is a consumer health and wellness company that targets under met consumer opportunities in the OTC marketplace. Our core strategy plans to meet the growing demand for personalized, consumer self-care solutions by leveraging proprietary innovation and healthcare technology with the rapid transformation of the healthcare marketplace to create innovative, science based solutions and brands. TriStar Wellness Solutions is owner of the Beaute de MamanTM brand of women’s health products. Additional information is available at www.tstarwellness.com and http://www.beautedemaman.com
Forward-Looking Statement
This press release for TriStar Wellness Solutions, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
Contacts
Dian Griesel Inc.
Cheryl Schneider/Susan Forman
212-825-3210
www.dgicomm.com
$TWSI TriStar Wellness Solutions Signs Exclusive Global Licensing Agreement With Argentum Medical’s Silverlon® Technology for OTC Wound Care Market
WESTPORT, Conn.--(BUSINESS WIRE)--TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a consumer health and wellness company that targets opportunities in the self-care and quality of life marketplace, has signed an exclusive, 15-year licensing agreement with Argentum Medical, LLC for its Silverlon® technology for the over-the-counter (“OTC”) wound care market.
“Stopping the bleeding, protecting the wound and preventing the wound from increasing in size are all important elements of an effective wound care product, and all are characteristics of our newly licensed technology.”
The licensing agreement enables TriStar Wellness Solutions to develop, market and sell OTC wound care products based on Silverlon’s proprietary silver coating technology, which provides superior performance for wound treatment. The technology, with its permanently plated metallic surface, reduces the occurrence of surgical site infections. Further terms of the agreement are included in TriStar Wellness Solutions’ 8-K which was filed with the Securities and Exchange Commission on March 14, 2013.
“We expect Silverlon’s patented technology to complement the OTC wound care solutions that we are currently developing,” said John Linderman, President and CEO of TriStar Wellness Solutions. “Stopping the bleeding, protecting the wound and preventing the wound from increasing in size are all important elements of an effective wound care product, and all are characteristics of our newly licensed technology.
“TriStar Wellness Solutions’ first wound care product addresses the nuisance bleeding portion of the market, and is in an area we believe has the potential for significant growth, targeting the unmet needs of approximately 50 million Americans. We intend to capitalize on Silverlon’s technology, develop new products, and use our marketing expertise to bring these products to market, adding to our growing portfolio of brands,” concluded Mr. Linderman.
TriStar Wellness Solutions recently acquired the Beauté de Maman™ brand of women’s health products, a company that sells products into the underserved market for pregnant and new mothers. The company’s three-phased growth strategy includes incubating and commercializing its foundational product portfolio, scaling that portfolio and expanding segment extensions via targeted brand acquisitions and then leveraging its total portfolio through major corporate acquisitions and potential joint ventures. Its core strategy aligns with the growing demand for simple, effective self-care solutions for a broad range of consumer conditions and disease states.
About TriStar Wellness Solutions
TriStar Wellness Solutions, Inc. (TWSI) is a consumer health and wellness company that targets under met consumer opportunities in the OTC marketplace. Our core strategy plans to meet the growing demand for personalized, consumer self-care solutions by leveraging proprietary innovation and healthcare technology with the rapid transformation of the healthcare marketplace to create innovative, science based solutions and brands. TriStar Wellness Solutions is owner of the Beaute de MamanTM brand of women’s health products.
Additional information is available at www.tstarwellness.com and http://www.beautedemaman.com.
Forward-Looking Statement
This press release for TriStar Wellness Solutions, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
Contacts
Dian Griesel Inc.
Cheryl Schneider/Susan Forman
212-825-3210
www.dgicomm.com
http://www.businesswire.com/news/home/20130321005330/en/TriStar-Wellness-Solutions-Signs-Exclusive-Global-Licensing
TriStar Wellness Solutions Acquires HemCon Medical Technologies
LINK
Developer of Bleeding and Wound Management Technologies for Surgical, Health Care,
Consumer and Military Markets to Operate as Wholly Owned Subsidiary of TriStar
Irlellness Solwticns
WESTPORT, CT - May 10,2013 - TriStar Wellness Solutions,Inc. (OTCBB: TWSI),
a health and wellness company that targets opportunities in the self-care and professional
marketplace, has acquired HemCon Medical Technologies Inc., a Portland, Oregon-based
leading researcher and manufacturer of products for bleeding and wound management.
TriStar purchased all the stock of HemCon for $3,075.000 in cash. Effective
immediately, HemCon will operate as a wholly owned subsidiary of TriStar.
HemCon, founded in 2001, had revenuesin201.2 of $6.5 million. Its world-class
manufacturing facility had received funding from the U.S. Department of Defense to
develop a hemorrhage-control bandage that became standard-issue for U.S. soldiers
fighting in Iraq and Afghanistan. In addition to its Portland facility, HemCon also has
facilities in Ireland and the Czech Republic.
The stock acquisition consisteci of the entire medical device business. TriStar has filed a
form 8-K with the Securities and Exchange Commission that contains further details of
the transaction.
Barq, S. Starkman, age 56, will retain his current position as President and Chief
Executive Officer of HemCon while also assuming the role of Senior Vice President of
TriStar. He will be based at HemCon's manufacturing facility in Portland, and will report
to John Linderman, President and CEO of TriStar Wellness Solutions.
John Linderman elaborated on the importance of this acquisition: "With its world-class
global operations and healthcare technology assets, HemCon represents a tremendous
opportunity for growth. HemCon will become the platform from which to launch
TriStar's plans to grow its consumer and professional wound care portfolio and become a
key player in the $17 billion global wound care market. HemCon's products,
technologies and best-in-class manufacturing capability will enable the company to
rapidly grow share through a pipeline of innovation designed to meet the needs of
underserved consumer and professional markets."
Mr. Linderman continued, "HemCon provides TriStar Wellness Solutions an ongoing
revenue base with significant near- and long-term growth potential. Now that it is part of
TriStar, we plan to implement strategies to leverage HemCon for aggressive commercial
success across a broad range of innovative technology applications within the U.S. and
global markets. We expect to refocus the impressive HemConorgaruzation on rebuilding
its core professional/surgical and emergency medical market customer base and to
penetrate new consumer markets with innovative new products that are currently in
de.,,eLopment.
"The HemCon acquisition enables TriStar's plans to build a major healthcare products
company focused on addressing unmet or under-met consumer and healthcare
professional needs. In the past year, TriStar has been focusing on acquiring new
technologies and assets; now with HemCon, we have a platform to more rapidly bring
these assets to the marketplace," he added.
Mr. Starkman commented, "With our acquisition by TriStar Wellness Solutions, we are
looking forward to launching an important new phase in the HemCon story. Under
TriStar ownership, HemCon will continue its mission to provide medical practitioners
worldwide with the highest-quality, most cost-effective solutions to bleeding and wound
care in all medical settings, from the emergent trauma through the OR to post-surgical
care, and to continue to provide quahty products for the OTC market."
I-IemCnn oirlerl hrr ,"'."...6 E,nr{ino lrnm lhp I T S, f)enorfmcnf nf T)elcnce dc.ralnned q hr^.Aee
for incorporating chitosan, a substance found in shrimp shells, into bandages that control
severe bleeding and are naturally antibacterial. Between 2003 and 2008, the HemCon@
Bandage was the standard-issuc hemtrrrhage-eoniroi bandage for allU.S. Anriy soidiers
and is credited with saving hundreds of lives on the battlefield in Iraq and Afghanistan.
HemCon subsequently extended its technologies into a diversified product line for the
emergency medical, surgical, dental, military and OTC markets in the U.S. and globally.
HemCon's premier product lines include GuardaCareXR Surgical Hemostatic Temporary
Surgical Dressing, a chitosan-coated gauze with an x-ray detectable element indicated for
the temporary control of severe bleeding; ChitoGauze*, an easy-to-apply dressing for the
military market that maximizes the limited time before massive blood loss turns deadly;
GuardaCare@, an emergency medicine variant of ChitoGauze@; the HemCon Patch@,
designed for bleeding control following heart catheterizationprocedures; the HemCon
Dental Dressing, designed for use by oral surgeons and general practitioners to protect
oral mucosal tissues following various procedures; and various products incorporating
m.docrM oxidized cellulose for the OTC market. Not included in the acquisition is
HemCon's freeze-dried plasma development program, which was spun off from the
company.
Dennis McNannay, Executive Director of the Oregon Bioscience Association, noted,
"Oregon Bio welcomes the news that HemCon, a local, innovative industry leader, is
transitioning its business platform. HemCon has not only been a significant contributor to
the Oregon economy, but also an essential catalyst to Oregon's innovation culture, rich
entrepreneurial history and the region's bioscience community. We're excited for
HemCon to begin this new chapter in its history."
About TriStar Wellness Solutions
TriStar Wellness Solutions, Inc. (TWSI) is a health and wellness company that targets
under met consumer opportunities in the OTC and professional marketplace. Our core
strategy plans to meet the growing demand for personalized, care solutions by leveraging
proprietary innovation and healthcare technology with the rapid transformation of the
healthcare marketplace to create innovative, science based solutions and brands.
Additional information is available at www. tstarwellne ss. c om.
About HemCon Medical Technologies
HemCon Medicai Technologies Inc., founded in2001, develops, manufactures, and
markets innovative technologies for rapid delivery of plasma and hemostatic devices for
the control of bleeding resulting from trauma or surgery. HemCon products are designed
for use by military and civilian first responders as well as medical professionals in
hospital and clinical settings where control of bleeding are of critical importance.
HemCon is headquartered in Portland, Ore., with additionai commerciai operations in
Ireland and the Czech Republic. For more information, please visit www.hemcon.com.
Forward-Looking Statement
This press release for TriStar Wellness Solutions, Inc. contains forward-looking
statements. Generally, you can identifu these statements because they use words like
"anticipates," "believes," "expects," "future," "intends," "Dlansr" and similar terms. These
statements reflect only our current expectations. Although we do not make forwardlooking statements unless we believe we have a reasonable basis for doing so, we cannot
guarantee their accuracy anC actual results may differ materially from those we
anticipated due to a number of uncertainties, many of which are unforeseen, including,
among others, the risks we face as described our filings with the Securities and Exchange
Commission. You should not place undue reliance on these forward-looking statements
which apply only as of the date of this press release. To the extent that such statements
are not recitations of historical fact, such statements constitute forward-looking
statements that, by definition, involve risks and uncertainties. In any forward-looking
statement where we express an expectation or belief as to future results or events, such
expectation or belief is expressed in good faith and believed to have a reasonable basis,
but there can be no assurance that the statement of expectation of belief will be
accomplished.
Contact:
n;-- rl;^.ol T-^ t/lqtl \rl tvJvr lllv.
Cheryl Schneider/Susan Forman
212-825-3210
www.dgicomm.conr
$TWSI there was a press release on the 10th?
http://shopsigg.fatcow.com/tristar/wp-content/uploads/2013/05/TriStarPressRelease051313.pdf
73% recommend Dr. Michele D. Brown, MD
http://www.healthgrades.com/physician/dr-michele-brown-xyxn8
#3 on Breakout Boards
$CWRN up 50% .0010 .0013